Illinois
Phase 1 cancer trials in Illinois
129 Phase 1 cancer studies are recruiting participants at sites in 23 cities across Illinois as of November 17, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Illinois city with a recruiting study
By research area: Lymphoma (37), Breast Cancer (36), Lung Cancer (32), Prostate Cancer (10), Pancreatic Cancer (8), Melanoma (6).
Chicago (102), Zion (11), Peoria (6), New Lenox (4), Orland Park (4), Shiloh (3), Skokie (3), Springfield (3), Urbana (3), Evanston (2), Hinsdale (2), Maywood (2), Oak Lawn (2), Arlington Heights (1), Calumet City (1), Decatur (1), Flossmoor (1), Harvey (1), Lake Barrington (1), Lisle (1), Park Ridge (1), Tinley Park (1), Winfield (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Breast cancer: recently updated in Illinois
Basic details from each study's public record (the 12 most recently updated of 129). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
- Phase 1
- Ages 18 and older
- Female participants
- Sponsor
- Totus Medicines
- Recruiting in
- Chicago
- Registry record
- NCT05683418 · updated
A Phase 1/2 Study of IAM1363 in HER2 Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Iambic Therapeutics, Inc
- Recruiting in
- Chicago
- Registry record
- NCT06253871 · updated
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Recruiting in
- Skokie
- Registry record
- NCT06324357 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Illinois on ClinicalTrials.gov.
Lung cancer: recently updated in Illinois
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Vivace Therapeutics, Inc
- Recruiting in
- Chicago
- Registry record
- NCT04665206 · updated
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Chicago · New Lenox · Orland Park
- Registry record
- NCT06287775 · updated
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Recruiting in
- Zion
- Registry record
- NCT07277413 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Illinois on ClinicalTrials.gov.
Prostate cancer: recently updated in Illinois
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Astellas Pharma Global Development, Inc.
- Recruiting in
- Zion
- Registry record
- NCT05997615 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Illinois on ClinicalTrials.gov.
Melanoma: recently updated in Illinois
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- Phase 1/2
- From 6 months, up to 17 years
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Chicago
- Registry record
- NCT02332668 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Illinois on ClinicalTrials.gov.
Lymphoma: recently updated in Illinois
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Recruiting in
- Chicago · Maywood · Oak Lawn · and 4 more U.S. locations
- Registry record
- NCT04726241 · updated
A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Debiopharm International SA
- Recruiting in
- Chicago
- Registry record
- NCT05765812 · updated
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
- Phase 1
- Ages 0 to 18
- All sexes
- Sponsor
- Autolus Limited
- Recruiting in
- Chicago
- Registry record
- NCT06173518 · updated
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- AstraZeneca
- Recruiting in
- Chicago
- Registry record
- NCT07109219 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Illinois on ClinicalTrials.gov.
Ask about studies in Illinois
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections